Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person ALK S1206Y [plasma membrane]
| Class:Id | EntityWithAccessionedSequence:9701426 |
|---|---|
| _displayName | ALK S1206Y [plasma membrane] |
| _timestamp | 2020-09-26 21:54:17 |
| compartment | [Compartment:876] plasma membrane |
| created | [InstanceEdit:9701436] Rothfels, Karen, 2020-09-26 |
| crossReference | [DatabaseIdentifier:9701280] COSMIC:COSV66566818 |
| disease | [Disease:8853117] lung adenocarcinoma |
| endCoordinate | 1620 |
| hasModifiedResidue | [ReplacedResidue:9701430] L-serine 1206 replaced with L-tyrosine |
| literatureReference | [LiteratureReference:9700350] The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer |
| name | ALK S1206Y ALK tyrosine kinase receptor ALK_HUMAN |
| referenceEntity | [ReferenceGeneProduct:49894] UniProt:Q9UM73 ALK [Homo sapiens] |
| species | [Species:48887] Homo sapiens |
| stableIdentifier | [StableIdentifier:9701444] R-HSA-9701426.1 |
| startCoordinate | 19 |
| (hasComponent) | [Complex:9701482] ALK S1206Y dimer [plasma membrane] [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by ALK S1206Y [plasma membrane] (9701426)
